Keyphrases
Renal Cell Carcinoma
100%
Sunitinib
100%
Spontaneous Regression
100%
Adrenal Metastasis
100%
Metastatic Renal Cell Carcinoma (mRCC)
28%
Metastasis
14%
Vascular Endothelial Growth Factor Receptor (VEGFR)
14%
Young Males
14%
Dual-target Inhibitor
14%
Outpatient Department
14%
Abdominal
14%
Gradual Reduction
14%
Excision
14%
Tumor Angiogenesis
14%
Clear Cell Type
14%
Nephrectomy
14%
Computerized Tomography
14%
Laparoscopic Partial Nephrectomy
14%
Gastrointestinal Side Effects
14%
Estimated Incidence
14%
Advanced Renal Cell Carcinoma
14%
Medicine and Dentistry
Spontaneous Remission
100%
Sunitinib
100%
Clear Cell Renal Cell Carcinoma
100%
Kidney Metastasis
28%
Recurrent Disease
14%
Metastatic Carcinoma
14%
Vasculotropin Receptor
14%
Computer Assisted Tomography
14%
Outpatient
14%
Tumor Angiogenesis
14%
Clear Cell
14%
Radical Nephrectomy
14%
Case Presentation
14%
Nephrectomy
14%
Gastrointestinal Distress
14%